Crohn’s Disease (M14-430)

Crohn’s disease is an inflammatory bowel disease (IBD). It causes inflammation of the lining of your digestive tract, which can lead to abdominal pain, severe diarrhea, fatigue, weight loss and malnutrition. Inflammation caused by Crohn’s disease can involve different areas of the digestive tract in different people.

The inflammation caused by Crohn’s disease often spreads deep into the layers of affected bowel tissue. Crohn’s disease can be both painful and debilitating, and sometimes may lead to life-threatening complications.

M14-430: A multicenter study to evaluate the efficacy and safety of maintenance and long-term treatment administration of upadacitinib, an orally administered Janus kinase 1 inhibitor, in adult participants with Crohn’s Disease who have completed studies M14-433 or M14-431.

Register Today!

Trial Information

Start DateVaries by study
End DateVaries by study
Trial DurationVaries by study
Number of VisitsVaries by study
StatusM14-430 - Ongoing Trial

For additional information
on this trial contact: